Valeant Pharmaceuticals (VRX) volatility stays elevated after less than expected Q3 and outlook

November 8, 2016 11:25 AM EST

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Valeant Pharma (NYSE: VRX) November weekly call option implied volatility is at 142, November is at 116, December is at 95; compared to its 52-week range of 53 to 173 after reporting less than expected Q3 results and outlook

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment